3. 2022 EAU A0958: A nationwide study on the added value of (neo)adjuvant ADT in addition to modern dose-escalated external beam radiotherapy in men with high-risk localized prostate cancer 4. 2022 ESMO LBA9 - Durat...
Early ADT for prostate cancer fails to improve survivalAndrogen deprivation therapy provides no survival benefit in older men with localized prostate cancer at 15 years, newly published research shows.Study findings, from Rutgers Cancer Institute ofRichard R. Kerr...
[1] 2022 ESMO- LBA9 - Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031). [2] Mottet, N., et al. EAU-...
Atalar K, Rajan P. Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer. Nat Rev Urol. 2022 Oct 24. doi: 10.1038/s41585-022-00671-5. Epub ahead of print. PMID: 36280769.
[1]2022 ESMO-LBA9-Duration of androgen deprivation therapy(ADT)with post-operative radiotherapy(RT)for prostate cancer:First results of the RADICALS-HD trial(ISRCTN40814031). [2]Mottet,N.,et al.EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer.Arnhem:European Association of Urology,20...
A new study has shown that once-weekly oral bisphosphonate can prevent and improve bone loss in men undergoing androgen deprivation therapy (ADT) for prostate cancer.doi:10.1038/ncpuro0791NoneNature Clinical Practice Urology
104 Orgasm in Men on Androgen Deprivation Therapy (ADT) for Prostate Cancerdoi:10.1016/j.jsxm.2016.02.111Mazzola, C.Teloken, P.E.Matsuhsita, K.Nelson, C.J.Mulhall, J.P.Elsevier Inc.Journal of Sexual Medicine
The standard curative treatment is radical prostatectomy (RP) or radiation therapy (RT) in localized prostate cancer (Pca). Unfortunately, at most 30% of the patients develop biochemical recurrent that can be identified by rising prostate-specific antigen (PSA) only but not detectable by CT scan...
[2]Ross RW, Xie W, Regan MM, et al. Efficacy of androgen deprivation therapy (Adt) in patients with advanced prostate cancer: Association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect. Cancer. 2008;112(6):1247-1253. ...
5061 Background: The role of ADT for men with node positive prostate cancer following radical prostatectomy (RP) is unclear. One randomized trial has shown a survival advantage for men treated with immediate adjuvant (adj) ADT compared treatment at onset of clinical metastases. However, benefit of...